Acorah Software Products - Accounts Production 19.1.200 false true 31 July 2024 1 August 2023 false true No description of principal activity 1 August 2024 31 July 2025 31 July 2025 NI671090 Dr Moulod El-Agnaf Dr Hana Dokali iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure NI671090 2024-07-31 NI671090 2025-07-31 NI671090 2024-08-01 2025-07-31 NI671090 frs-core:CurrentFinancialInstruments 2025-07-31 NI671090 frs-bus:PrivateLimitedCompanyLtd 2024-08-01 2025-07-31 NI671090 frs-bus:FilletedAccounts 2024-08-01 2025-07-31 NI671090 frs-bus:Micro-entities 2024-08-01 2025-07-31 NI671090 frs-bus:AuditExempt-NoAccountantsReport 2024-08-01 2025-07-31 NI671090 frs-bus:Director1 2024-08-01 2025-07-31 NI671090 frs-bus:CompanySecretary1 2024-08-01 2025-07-31 NI671090 2023-07-31 NI671090 2024-07-31 NI671090 2023-08-01 2024-07-31 NI671090 frs-core:CurrentFinancialInstruments 2024-07-31
Registered number: NI671090
Haematology Treatment Hub Ltd
Financial Statements
For The Year Ended 31 July 2025
Mibsons Limited
Chartered Certified Accountants
51 Coopers Road
Handsworth Wood
Birmingham
B20 2JU
Balance Sheet
Registered number: NI671090
2025 2024
£ £
Fixed assets 304 453
Current assets 54,469 76,763
Creditors: Amounts Falling Due Within One Year (27,890 ) (48,018 )
NET CURRENT ASSETS 26,579 28,745
TOTAL ASSETS LESS CURRENT LIABILITIES 26,883 29,198
Accruals and deferred income (960 ) (960 )
NET ASSETS 25,923 28,238
CAPITAL AND RESERVES 25,923 28,238

Notes

1. General Information
Haematology Treatment Hub Ltd is a private company, limited by shares, incorporated in England & Wales, registered number NI671090 . The registered office is 3 Greer Park Avenue, Belfast, Northern Ireland, BT8 7YF.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2024: 2)
1 2
For the year ending 31 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr Moulod El-Agnaf
Director
22nd April 2026